Blood‐based biomarkers for Alzheimer's disease
Abstract Neurodegenerative disorders such as Alzheimer's disease (AD) represent a mounting public health challenge. As these diseases are difficult to diagnose clinically, biomarkers of underlying pathophysiology are playing an ever‐increasing role in research, clinical trials, and in the clini...
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Springer Nature
2021-12-01
|
| Reeks: | EMBO Molecular Medicine |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.15252/emmm.202114408 |